A multi-country cohort database study to assess pregnancy and infant outcomes after potential maternal or paternal exposure to cladribine tablets in the treatment of multiple sclerosis: the CLEAR study methods and status update

Background: Cladribine tablets are contraindicated during pregnancy; therefore, safety data on pregnancies exposed to this treatment are limited. CLEAR collects and describes pregnancy outcomes in this understudied population. Objectives: To describe the main features of the CLEAR study design, incl...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Kerstin Hellwig, Melinda Magyari, Thomas M. MacDonald, Carolyn E. Cesta, Stig Wergeland, Maarit K. Leinonen, Asher Ornoy, Sandra Vukusic, Alexandra Lauer, Xiaolei Zhou, Alison Kawai, Rachel Weinrib, Alejandro Arana, Tahani Boumenna
Formato:	Artigo
Idioma:	Inglês
Publicado em:	SAGE Publishing 2025-01-01
coleção:	Therapeutic Advances in Neurological Disorders
Acesso em linha:	https://doi.org/10.1177/17562864241310996
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!